New: 100 biomarkers for $190
Macrocyclic peptides: a new "Goldilocks" drug class?

Macrocyclic peptides: a new "Goldilocks" drug class?

Merck ran more than a dozen screens for a small molecule that could block PCSK9 and found nothing. The drug that finally worked is a ring-shaped peptide, and it took 13 years.

• Brandon Ballinger